{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:36:01Z","timestamp":1792884961241,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00210-026-05697-9","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:12:10Z","timestamp":1783577530000},"page":"20151-20169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunotherapeutic modalities for combating multidrug-resistant bacteria: therapeutic promises of antibodies and next-generation vaccines"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9780-9305","authenticated-orcid":false,"given":"Nada","family":"Alkhorayef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"5697_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.molimm.2021.06.002","volume":"136","author":"TS Ahmadi","year":"2021","unstructured":"Ahmadi TS, Mousavi Gargari SL, Talei D (2021) Anti-flagellin IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound murine models in a non-type-specific mode. Mol Immunol 136:118\u2013127","journal-title":"Mol Immunol"},{"key":"5697_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100081","volume":"2","author":"SK Ahmed","year":"2024","unstructured":"Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA, Mohamed MG (2024) Antimicrobial resistance: impacts, challenges, and future prospects. J Med Surg Public Health 2:100081","journal-title":"J Med Surg Public Health"},{"key":"5697_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050665","volume":"10","author":"TH Albekairi","year":"2022","unstructured":"Albekairi TH, Alshammari A, Alharbi M, Alshammary AF, Tahir ul Qamar M, Ullah A, Irfan M, Ahmad S (2022) Designing of a novel multi-antigenic epitope-based vaccine against E. hormaechei: an intergraded reverse vaccinology and immunoinformatics approach. Vaccines 10:665","journal-title":"Vaccines"},{"key":"5697_CR4","doi-asserted-by":"publisher","unstructured":"Aldhaheri A, Alyabes O, Aljumaah S, Alhuthil R, Alonazi R, Alamoudi S, Alsuhaibani M, Alghamdi S, Albanyan EA, Al-Hajjar S, Mohammed R, Arnaout R, Albuhairi S, Alrumayyan N, Al-Saud B, Al-Mousa H (2025) The effects of postponing BCG vaccination on the risk of BCG-related complications among patients with severe combined immunodeficiency disease in Saudi Arabia. Front Immunol 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1596963","DOI":"10.3389\/fimmu.2025.1596963"},{"key":"5697_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jgeb.2017.10.003","volume":"16","author":"WA Amro","year":"2018","unstructured":"Amro WA, Al-Qaisi W, Al-Razem F (2018) Production and purification of IgY antibodies from chicken egg yolk. J Genet Eng Biotechnol 16:99\u2013103","journal-title":"J Genet Eng Biotechnol"},{"key":"5697_CR6","first-page":"669","volume":"22","author":"H Ansari","year":"2019","unstructured":"Ansari H, Tahmasebi-Birgani M, Bijanzadeh M, Doosti A, Kargar M (2019) Study of the immunogenicity of outer membrane protein A (ompA) gene from Acinetobacter baumannii as DNA vaccine candidate in vivo. Iran J Basic Med Sci 22:669\u2013675","journal-title":"Iran J Basic Med Sci"},{"key":"5697_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/21505594.2017.1306620","volume":"8","author":"R Babb","year":"2017","unstructured":"Babb R, Pirofski L-a (2017) Help is on the way: monoclonal antibody therapy for multi-drug resistant bacteria. Virulence 8:1055\u20131058","journal-title":"Virulence"},{"key":"5697_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, Sahly HME, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384:403\u2013416","journal-title":"N Engl J Med"},{"key":"5697_CR9","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1073\/pnas.1717160115","volume":"115","author":"SJ Baker","year":"2018","unstructured":"Baker SJ, Payne DJ, Rappuoli R, De Gregorio E (2018) Technologies to address antimicrobial resistance. Proc Natl Acad Sci U S A 115:12887\u201312895","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5697_CR10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier AJ, Jiang AY, Zhang P, Wooster R, Anderson DG (2022) The clinical progress of mRNA vaccines and immunotherapies. Nat Biotechnol 40:840\u2013854","journal-title":"Nat Biotechnol"},{"key":"5697_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/ph15060756","volume":"15","author":"C Bayart","year":"2022","unstructured":"Bayart C, Mularoni A, Hemmani N, Kerachni S, Jose J, Gouet P, Paladino J, Le Borgne M (2022) Tetanus toxin fragment C: structure, drug discovery research and production. Pharmaceuticals 15:756","journal-title":"Pharmaceuticals"},{"key":"5697_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","volume":"13","author":"AC Berical","year":"2016","unstructured":"Berical AC, Harris D, Dela Cruz CS, Possick JD (2016) Pneumococcal vaccination strategies. An update and perspective. Ann Am Thorac Soc 13:933\u2013944","journal-title":"Ann Am Thorac Soc"},{"key":"5697_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1473-3099(21)00627-7","volume":"22","author":"R Birger","year":"2022","unstructured":"Birger R, Antill\u00f3n M, Bilcke J, Dolecek C, Dougan G, Pollard AJ, Neuzil KM, Frost I, Laxminarayan R, Pitzer VE (2022) Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study. Lancet Infect Dis 22:679\u2013691","journal-title":"Lancet Infect Dis"},{"key":"5697_CR14","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/cid\/ciac881","volume":"76","author":"AM Blossey","year":"2023","unstructured":"Blossey AM, Br\u00fcckner S, May M, Parzmair GP, Sharma H, Shaligram U, Grode L, Kaufmann SHE, Netea MG, Schindler C (2023) VPM1002 as prophylaxis against severe respiratory tract infections including Coronavirus Disease 2019 in the elderly: a phase 3 randomized, double-blind, placebo-controlled, multicenter clinical study. Clin Infect Dis 76:1304\u20131310","journal-title":"Clin Infect Dis"},{"key":"5697_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2228669","volume":"19","author":"M Brazzoli","year":"2023","unstructured":"Brazzoli M, Piccioli D, Marchetti F (2023) Challenges in development of vaccines directed toward antimicrobial resistant bacterial species. Hum Vaccin Immunother 19:2228669","journal-title":"Hum Vaccin Immunother"},{"key":"5697_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/sur.2017.282","volume":"19","author":"SA Buckman","year":"2018","unstructured":"Buckman SA, Turnbull IR, Mazuski JE (2018) Empiric antibiotics for sepsis. Surg Infect 19:147\u2013154","journal-title":"Surg Infect"},{"key":"5697_CR17","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/microorganisms10030560","volume":"10","author":"T Chandler","year":"2022","unstructured":"Chandler T, Furmanek S, Carrico R, Balcom D, Arnold F, Ramirez J (2022) 23-Valent pneumococcal polysaccharide vaccination does not prevent community-acquired pneumonia hospitalizations due to vaccine-type Streptococcus pneumoniae. Microorganisms 10:560","journal-title":"Microorganisms"},{"key":"5697_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/life14020246","author":"HC Chen","year":"2024","unstructured":"Chen HC, Pan YL, Chen Y, Yang TH, Hsu ET, Huang YT, Chiang MH (2024) Monoclonal antibodies as a therapeutic strategy against multidrug-resistant bacterial infections in a post-COVID-19 era. Life (Basel). https:\/\/doi.org\/10.3390\/life14020246","journal-title":"Life (Basel)"},{"key":"5697_CR19","volume":"7","author":"KL Chin","year":"2024","unstructured":"Chin KL, Anibarro L, Chang ZY, Palasuberniam P, Mustapha ZA, Sarmiento ME, Acosta A (2024) Impacts of MDR\/XDR-TB on the global tuberculosis epidemic: challenges and opportunities. Curr Res Microb Sci 7:100295","journal-title":"Curr Res Microb Sci"},{"key":"5697_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112047","volume":"142","author":"G Chiwala","year":"2021","unstructured":"Chiwala G, Liu Z, Mugweru JN, Wang B, Khan SA, Bate PNN, Yusuf B, Hameed HMA, Fang C, Tan Y, Guan P, Hu J, Tan S, Liu J, Zhong N, Zhang T (2021) A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen. Biomed Pharmacother 142:112047","journal-title":"Biomed Pharmacother"},{"key":"5697_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131379","volume":"266","author":"PK Das","year":"2024","unstructured":"Das PK, Sahoo A, Veeranki VD (2024) Recombinant monoclonal antibody production in yeasts: challenges and considerations. Int J Biol Macromol 266:131379","journal-title":"Int J Biol Macromol"},{"key":"5697_CR22","doi-asserted-by":"crossref","unstructured":"DiGiandomenico A, Keller AE, Gao C, Rainey GJ, Warrener P, Camara MM, Bonnell J, Fleming R, Bezabeh B, Dimasi N, Sellman BR, Hilliard J, Guenther CM, Datta V, Zhao W, Gao C, Yu X-Q, Suzich JA, Stover CK (2014) A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Sci Transl Med 6:262ra155\u2013262ra155","DOI":"10.1126\/scitranslmed.3009655"},{"key":"5697_CR23","doi-asserted-by":"publisher","unstructured":"Dockrell HM, Smith SG (2017) What have we learnt about BCG Vaccination in the Last 20 Years?\u00a0Front Immunol\u00a08. https:\/\/doi.org\/10.3389\/fimmu.2017.01134","DOI":"10.3389\/fimmu.2017.01134"},{"key":"5697_CR24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1473-3099(16)30132-3","volume":"16","author":"PJ Dodd","year":"2016","unstructured":"Dodd PJ, Sismanidis C, Seddon JA (2016) Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Lancet Infect Dis 16:1193\u20131201","journal-title":"Lancet Infect Dis"},{"key":"5697_CR25","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1080\/07391102.2018.1519460","volume":"37","author":"H Dorosti","year":"2019","unstructured":"Dorosti H, Eslami M, Negahdaripour M, Ghoshoon MB, Gholami A, Heidari R, Dehshahri A, Erfani N, Nezafat N, Ghasemi Y (2019) Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine. J Biomol Struct Dyn 37:3524\u20133535","journal-title":"J Biomol Struct Dyn"},{"key":"5697_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1084\/jem.20180448","volume":"216","author":"J Durack","year":"2019","unstructured":"Durack J, Lynch SV (2019) The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med 216:20\u201340","journal-title":"J Exp Med"},{"key":"5697_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijantimicag.2018.11.010","volume":"53","author":"GA Durand","year":"2019","unstructured":"Durand GA, Raoult D, Dubourg G (2019) Antibiotic discovery: history, methods and perspectives. Int J Antimicrob Agents 53:371\u2013382","journal-title":"Int J Antimicrob Agents"},{"key":"5697_CR28","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.vaccine.2019.01.080","volume":"37","author":"SP Fitzwater","year":"2019","unstructured":"Fitzwater SP, Ramachandran P, Kahn GD, Nedunchelian K, Suresh S, Santosham M, Chandran A (2019) Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India. Vaccine 37:1608\u20131613","journal-title":"Vaccine"},{"key":"5697_CR29","doi-asserted-by":"publisher","unstructured":"Fleming JA, Gurley N, Knudson S, Kabore L, Bawa JT, Dapaah P, Kumar S, Uranw S, Tran T, Mai LTP, Odero C, Obong'oC, Aburam K, Wanjiru S, Hanh NTM, Dung LP, Hausdorff WP (2023) Exploring Shigella vaccine priorities and preferences: results from a mixed-methods study in low- and middle-income settings. Vaccine: X 15:100368. https:\/\/doi.org\/10.1016\/j.jvacx.2023.100368","DOI":"10.1016\/j.jvacx.2023.100368"},{"key":"5697_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164692","volume":"11","author":"A Flood","year":"2016","unstructured":"Flood A, Estrada M, McAdams D, Ji Y, Chen D (2016) Development of a freeze-dried, heat-stable influenza subunit vaccine formulation. PLoS One 11:e0164692","journal-title":"PLoS ONE"},{"key":"5697_CR31","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/S2666-5247(22)00303-2","volume":"4","author":"I Frost","year":"2023","unstructured":"Frost I, Sati H, Garcia-Vello P, Hasso-Agopsowicz M, Lienhardt C, Gigante V, Beyer P (2023) The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline. Lancet Microbe 4:e113\u2013e125","journal-title":"Lancet Microbe"},{"key":"5697_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20731-x","volume":"12","author":"H Fu","year":"2021","unstructured":"Fu H, Lewnard JA, Frost I, Laxminarayan R, Arinaminpathy N (2021) Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine. Nat Commun 12:424","journal-title":"Nat Commun"},{"key":"5697_CR33","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1111\/apa.13072","volume":"104","author":"C Gagliotti","year":"2015","unstructured":"Gagliotti C, Buttazzi R, Di Mario S, Morsillo F, Moro ML (2015) A regionwide intervention to promote appropriate antibiotic use in children reversed trends in erythromycin resistance to Streptococcus pyogenes. Acta Paediatr 104:e422\u2013e424","journal-title":"Acta Paediatr"},{"key":"5697_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.xphs.2019.05.031","volume":"109","author":"DR Goulet","year":"2020","unstructured":"Goulet DR, Atkins WM (2020) Considerations for the design of antibody-based therapeutics. J Pharm Sci 109:74\u2013103","journal-title":"J Pharm Sci"},{"key":"5697_CR35","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","volume":"31","author":"L Grode","year":"2013","unstructured":"Grode L, Ganoza CA, Brohm C, Weiner J, Eisele B, Kaufmann SHE (2013) Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. Vaccine 31:1340\u20131348","journal-title":"Vaccine"},{"key":"5697_CR36","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1172\/JCI24617","volume":"115","author":"L Grode","year":"2005","unstructured":"Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Eddine A, Mann P, Goosmann C, Bandermann S, Smith D, Bancroft GJ, Reyrat JM, van Soolingen D, Raupach B, Kaufmann SH (2005) Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin. J Clin Invest 115:2472\u20132479","journal-title":"J Clin Invest"},{"key":"5697_CR37","doi-asserted-by":"publisher","unstructured":"Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, Gerges-Geagea A, Leone A, Jurjus A (2015) Vaccines through centuries: major cornerstones of global health.\u00a0Front Public Health\u00a03. https:\/\/doi.org\/10.3389\/fpubh.2015.00269","DOI":"10.3389\/fpubh.2015.00269"},{"key":"5697_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11033-018-4167-y","volume":"45","author":"R Hashemzehi","year":"2018","unstructured":"Hashemzehi R, Doosti A, Kargar M, Jaafarinia M (2018) Cloning and expression of nlpA gene as DNA vaccine candidate against Acinetobacter baumannii. Mol Biol Rep 45:395\u2013401","journal-title":"Mol Biol Rep"},{"key":"5697_CR39","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.vaccine.2024.06.017","volume":"42","author":"M Hasso-Agopsowicz","year":"2024","unstructured":"Hasso-Agopsowicz M, Sparrow E, Cameron AM, Sati H, Srikantiah P, Gottlieb S, Bentsi-Enchill A, Le Doare K, Hamel M, Giersing BK, Hausdorff WP (2024) The role of vaccines in reducing antimicrobial resistance: a review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens. Vaccine 42:S1\u2013S8","journal-title":"Vaccine"},{"key":"5697_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2025.100896","volume":"56","author":"AR Heamchandsaravanan","year":"2025","unstructured":"Heamchandsaravanan AR, Perumal D, Nandha RV, Dhandapani P (2025) Advancing beyond conventional vaccines: the potential of next-generation vaccines in combatting antibiotic-resistant bacteria. Indian J Med Microbiol 56:100896","journal-title":"Indian J Med Microbiol"},{"key":"5697_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/19490976.2015.1062959","volume":"6","author":"F-A Heinsen","year":"2015","unstructured":"Heinsen F-A, Knecht H, Neulinger SC, Schmitz RA, Knecht C, K\u00fchbacher T, Rosenstiel PC, Schreiber S, Friedrichs AK, Ott SJ (2015) Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin. Gut Microbes 6:243\u2013254","journal-title":"Gut Microbes"},{"key":"5697_CR42","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.trecan.2024.07.002","volume":"10","author":"M Herrera","year":"2024","unstructured":"Herrera M, Pretelli G, Desai J, Garralda E, Siu LL, Steiner TM, Au L (2024) Bispecific antibodies: advancing precision oncology. Trends Cancer 10:893\u2013919","journal-title":"Trends in Cancer"},{"key":"5697_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.07.010","author":"CS Ho","year":"2025","unstructured":"Ho CS, Wong CTH, Aung TT, Lakshminarayanan R, Mehta JS, Rauz S, McNally A, Kintses B, Peacock SJ, de la Fuente-Nunez C, Hancock REW, Ting DSJ (2025) Antimicrobial resistance: a concise update. Lancet Microbe. https:\/\/doi.org\/10.1016\/j.lanmic.2024.07.010","journal-title":"Lancet Microbe"},{"key":"5697_CR44","doi-asserted-by":"crossref","unstructured":"Hoelzer K, Bielke L, Blake DP, Cox E, Cutting SM, Devriendt B, Erlacher-Vindel E, Goossens E, Karaca K, Lemiere S, Metzner M, Raicek M, Collell Suri\u00f1ach M, Wong NM, Gay C, Van Immerseel F (2018) Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs. Vet Res 49:64","DOI":"10.1186\/s13567-018-0560-8"},{"key":"5697_CR45","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1177\/1060028017713029","volume":"51","author":"AW Hou","year":"2017","unstructured":"Hou AW, Morrill AM (2017) Obiltoxaximab: adding to the treatment arsenal for Bacillus anthracis infection. Ann Pharmacother 51:908\u2013913","journal-title":"Ann Pharmacother"},{"key":"5697_CR46","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1128\/AAC.01165-15","volume":"59","author":"RM Humphries","year":"2015","unstructured":"Humphries RM, Yang S, Hemarajata P, Ward KW, Hindler JA, Miller SA, Gregson A (2015) First report of ceftazidime-avibactam resistance in a KPC-3-expressing Klebsiella pneumoniae isolate. Antimicrob Agents Chemother 59:6605\u20136607","journal-title":"Antimicrob Agents Chemother"},{"key":"5697_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02929-0","volume":"21","author":"R Hutubessy","year":"2023","unstructured":"Hutubessy R, Lauer JA, Giersing B, Sim SY, Jit M, Kaslow D, Botwright S (2023) The full value of vaccine assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making. BMC Med 21:229","journal-title":"BMC Med"},{"key":"5697_CR48","unstructured":"Ikuta KS, Swetschinski LR, Robles Aguilar G, Sharara F, Mestrovic T, Gray AP, Davis Weaver N, Wool EE, Han C, Gershberg Hayoon A, Aali A, Abate SM, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abd-Elsalam S, Abebe G, Abedi A, Abhari AP, Abidi H, Aboagye RG, Absalan A, Abubaker Ali H, Acuna JM, Adane TD, Addo IY, Adegboye OA, Adnan M, Adnani QES, Afzal MS, Afzal S, Aghdam ZB, Ahinkorah BO, Ahmad A, Ahmad AR, Ahmad R, Ahmad S, Ahmad S, Ahmadi S, Ahmed A, Ahmed H, Ahmed JQ, Ahmed Rashid T, Ajami M, Aji B, Akbarzadeh-Khiavi M, Akunna CJ, Al Hamad H, Alahdab F, Al-Aly Z, Aldeyab MA, Aleman AV, Alhalaiqa FAN, Alhassan RK, Ali BA, Ali L, Ali SS, Alimohamadi Y, Alipour V, Alizadeh A, Aljunid SM, Allel K, Almustanyir S, Ameyaw EK, Amit AML, Anandavelane N, Ancuceanu R, Andrei CL, Andrei T, Anggraini D, Ansar A, Anyasodor AE, Arabloo J, Aravkin AY, Areda D, Aripov T, Artamonov AA, Arulappan J, Aruleba RT, Asaduzzaman M, Ashraf T, Athari SS, Atlaw D, Attia S, Ausloos M, Awoke T, Ayala Quintanilla BP, Ayana TM, Azadnajafabad S, Azari Jafari A, B DB, Badar M, Badiye AD, Baghcheghi N, Bagherieh S, Baig AA, Banerjee I, Barac A, Bardhan M, Barone-Adesi F, Barqawi HJ, Barrow A, Baskaran P, Basu S, Batiha A-MM, Bedi N, Belete MA, Belgaumi UI, Bender RG, Bhandari B, Bhandari D, Bhardwaj P, Bhaskar S, Bhattacharyya K, Bhattarai S, Bitaraf S, Buonsenso D, Butt ZA, Caetano dos Santos FL, Cai J, Calina D, Camargos P, C\u00e1mera LA, C\u00e1rdenas R, Cevik M, Chadwick J, Charan J, Chaurasia A, Ching PR, Choudhari SG, Chowdhury EK, Chowdhury FR, Chu D-T, Chukwu IS, Dadras O, Dagnaw FT, Dai X, Das S, Dastiridou A, Debela SA, Demisse FW, Demissie S, Dereje D, Derese M, Desai HD, Dessalegn FN, Dessalegni SAA, Desye B, Dhaduk K, Dhimal M, Dhingra S, Diao N, Diaz D, Djalalinia S, Dodangeh M, Dongarwar D, Dora BT, Dorostkar F, Dsouza HL, Dubljanin E, Dunachie SJ, Durojaiye OC, Edinur HA, Ejigu HB, Ekholuenetale M, Ekundayo TC, El-Abid H, Elhadi M, Elmonem MA, Emami A, Engelbert Bain L, Enyew DB, Erkhembayar R, Eshrati B, Etaee F, Fagbamigbe AF, Falahi S, Fallahzadeh A, Faraon EJA, Fatehizadeh A, Fekadu G, Fernandes JC, Ferrari A, Fetensa G, Filip I, Fischer F, Foroutan M, Gaal PA, Gadanya MA, Gaidhane AM, Ganesan B, Gebrehiwot M, Ghanbari R, Ghasemi Nour M, Ghashghaee A, Gholamrezanezhad A, Gholizadeh A, Golechha M, Goleij P, Golinelli D, Goodridge A, Gunawardane DA, Guo Y, Gupta RD, Gupta S, Gupta VB, Gupta VK, Guta A, Habibzadeh P, Haddadi Avval A, Halwani R, Hanif A, Hannan MA, Harapan H, Hassan S, Hassankhani H, Hayat K, Heibati B, Heidari G, Heidari M, Heidari-Soureshjani R, Herteliu C, Heyi DZ, Hezam K, Hoogar P, Horita N, Hossain MM, Hosseinzadeh M, Hostiuc M, Hostiuc S, Hoveidamanesh S, Huang J, Hussain S, Hussein NR, Ibitoye SE, Ilesanmi OS, Ilic IM, Ilic MD, Imam MT, Immurana M, Inbaraj LR, Iradukunda A, Ismail NE, Iwu CCD, Iwu CJ, J LM, Jakovljevic M, Jamshidi E, Javaheri T, Javanmardi F, Javidnia J, Jayapal SK, Jayarajah U, Jebai R, Jha RP, Joo T, Joseph N, Joukar F, Jozwiak JJ, Kacimi SEO, Kadashetti V, Kalankesh LR, Kalhor R, Kamal VK, Kandel H, Kapoor N, Karkhah S, Kassa BG, Kassebaum NJ, Katoto PDMC, Keykhaei M, Khajuria H, Khan A, Khan IA, Khan M, Khan MN, Khan MAB, Khatatbeh MM, Khater MM, Khayat Kashani HR, Khubchandani J, Kim H, Kim MS, Kimokoti RW, Kissoon N, Kochhar S, Kompani F, Kosen S, Koul PA, Koulmane Laxminarayana SL, Krapp Lopez F, Krishan K, Krishnamoorthy V, Kulkarni V, Kumar N, Kurmi OP, Kuttikkattu A, Kyu HH, Lal DK, L\u00e1m J, Landires I, Lasrado S, Lee S-w, Lenzi J, Lewycka S, Li S, Lim SS, Liu W, Lodha R, Loftus MJ, Lohiya A, Lorenzovici L, Lotfi M, Mahmoodpoor A, Mahmoud MA, Mahmoudi R, Majeed A, Majidpoor J, Makki A, Mamo GA, Manla Y, Martorell M, Matei CN, McManigal B, Mehrabi Nasab E, Mehrotra R, Melese A, Mendoza-Cano O, Menezes RG, Mentis A-FA, Micha G, Michalek IM, Micheletti Gomide Nogueira de S\u00e1 AC, Milevska Kostova N, Mir SA, Mirghafourvand M, Mirmoeeni S, Mirrakhimov EM, Mirza-Aghazadeh-Attari M, Misganaw AS, Misganaw A, Misra S, Mohammadi E, Mohammadi M, Mohammadian-Hafshejani A, Mohammed S, Mohan S, Mohseni M, Mokdad AH, Momtazmanesh S, Monasta L, Moore CE, Moradi M, Moradi Sarabi M, Morrison SD, Motaghinejad M, Mousavi Isfahani H, Mousavi Khaneghah A, Mousavi-Aghdas SA, Mubarik S, Mulita F, Mulu GBB, Munro SB, Muthupandian S, Nair TS, Naqvi AA, Narang H, Natto ZS, Naveed M, Nayak BP, Naz S, Negoi I, Nejadghaderi SA, Neupane Kandel S, Ngwa CH, Niazi RK, Nogueira de S\u00e1 AT, Noroozi N, Nouraei H, Nowroozi A, Nu\u00f1ez-Samudio V, Nutor JJ, Nzoputam CI, Nzoputam OJ, Oancea B, Obaidur RM, Ojha VA, Okekunle AP, Okonji OC, Olagunju AT, Olusanya BO, Omar Bali A, Omer E, Otstavnov N, Oumer B, P A M, Padubidri JR, Pakshir K, Palicz T, Pana A, Pardhan S, Paredes JL, Parekh U, Park E-C, Park S, Pathak A, Paudel R, Paudel U, Pawar S, Pazoki Toroudi H, Peng M, Pensato U, Pepito VCF, Pereira M, Peres MFP, Perico N, Petcu I-R, Piracha ZZ, Podder I, Pokhrel N, Poluru R, Postma MJ, Pourtaheri N, Prashant A, Qattea I, Rabiee M, Rabiee N, Radfar A, Raeghi S, Rafiei S, Raghav PR, Rahbarnia L, Rahimi-Movaghar V, Rahman M, Rahman MA, Rahmani AM, Rahmanian V, Ram P, Ranjha MMAN, Rao SJ, Rashidi M-M, Rasul A, Ratan ZA, Rawaf S, Rawassizadeh R, Razeghinia MS, Redwan EMM, Regasa MT, Remuzzi G, Reta MA, Rezaei N, Rezapour A, Riad A, Ripon RK, Rudd KE, Saddik B, Sadeghian S, Saeed U, Safaei M, Safary A, Safi SZ, Sahebazzamani M, Sahebkar A, Sahoo H, Salahi S, Salahi S, Salari H, Salehi S, Samadi Kafil H, Samy AM, Sanadgol N, Sankararaman S, Sanmarchi F, Sathian B, Sawhney M, Saya GK, Senthilkumaran S, Seylani A, Shah PA, Shaikh MA, Shaker E, Shakhmardanov MZ, Sharew MM, Sharifi-Razavi A, Sharma P, Sheikhi RA, Sheikhy A, Shetty PH, Shigematsu M, Shin JI, Shirzad-Aski H, Shivakumar KM, Shobeiri P, Shorofi SA, Shrestha S, Sibhat MM, Sidemo NB, Sikder MK, Silva LMLR, Singh JA, Singh P, Singh S, Siraj MS, Siwal SS, Skryabin VY, Skryabina AA, Socea B, Solomon DD, Song Y, Sreeramareddy CT, Suleman M, Suliankatchi Abdulkader R, Sultana S, Sz\u00f3cska M, Tabatabaeizadeh S-A, Tabish M, Taheri M, Taki E, Tan K-K, Tandukar S, Tat NY, Tat VY, Tefera BN, Tefera YM, Temesgen G, Temsah M-H, Tharwat S, Thiyagarajan A, Tleyjeh II, Troeger CE, Umapathi KK, Upadhyay E, Valadan Tahbaz S, Valdez PR, Van den Eynde J, van Doorn HR, Vaziri S, Verras G-I, Viswanathan H, Vo B, Waris A, Wassie GT, Wickramasinghe ND, Yaghoubi S, Yahya GATY, Yahyazadeh Jabbari SH, Yigit A, Yi\u011fit V, Yon DK, Yonemoto N, Zahir M, Zaman BA, Zaman SB, Zangiabadian M, Zare I, Zastrozhin MS, Zhang Z-J, Zheng P, Zhong C, Zoladl M, Zumla A, Hay SI, Dolecek C, Sartorius B, Murray CJL, Naghavi M (2022) Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400:2221\u20132248"},{"key":"5697_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/vaccines10020199","volume":"10","author":"HR Jahantigh","year":"2022","unstructured":"Jahantigh HR, Faezi S, Habibi M, Mahdavi M, Stufano A, Lovreglio P, Ahmadi K (2022) The candidate antigens to achieving an effective vaccine against Staphylococcus aureus. Vaccines (Basel) 10:199","journal-title":"Vaccines (Basel)"},{"key":"5697_CR50","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1080\/21645515.2018.1476814","volume":"14","author":"KU Jansen","year":"2018","unstructured":"Jansen KU, Anderson AS (2018) The role of vaccines in fighting antimicrobial resistance (AMR). Hum Vaccin Immunother 14:2142\u20132149","journal-title":"Hum Vaccin Immunother"},{"key":"5697_CR51","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/dta.3562","volume":"15","author":"J Jung","year":"2023","unstructured":"Jung J, Jeong Y, Xu Y, Yi J, Kim M, Jeong H-J, Shin SH, Yang Y-H, Son J, Sung C (2023) Production and engineering of nanobody-based quenchbody sensors for detecting recombinant human growth hormone and its isoforms. Drug Test Anal 15:1439\u20131448","journal-title":"Drug Test Anal"},{"key":"5697_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071264","volume":"11","author":"K Khalid","year":"2023","unstructured":"Khalid K, Poh CL (2023) The promising potential of reverse vaccinology-based next-generation vaccine development over conventional vaccines against antibiotic-resistant bacteria. Vaccines 11:1264","journal-title":"Vaccines"},{"key":"5697_CR53","doi-asserted-by":"publisher","first-page":"12896","DOI":"10.1073\/pnas.1721095115","volume":"115","author":"KP Klugman","year":"2018","unstructured":"Klugman KP, Black S (2018) Impact of existing vaccines in reducing antibiotic resistance: primary and secondary effects. Proc Natl Acad Sci U S A 115:12896\u201312901","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5697_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1036","volume":"9","author":"E Kon","year":"2023","unstructured":"Kon E, Levy Y, Elia U, Cohen H, Hazan-Halevy I, Aftalion M, Ezra A, Bar-Haim E, Naidu GS, Diesendruck Y, Rotem S, Ad-El N, Goldsmith M, Mamroud E, Peer D, Cohen O (2023) A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Sci Adv 9:eadg1036","journal-title":"Sci Adv"},{"key":"5697_CR55","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/vaccines11030695","volume":"11","author":"M Kozak","year":"2023","unstructured":"Kozak M, Hu J (2023) The integrated consideration of vaccine platforms, adjuvants, and delivery routes for successful vaccine development. Vaccines 11:695","journal-title":"Vaccines"},{"key":"5697_CR56","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/phar.1990","volume":"37","author":"WD Kufel","year":"2017","unstructured":"Kufel WD, Devanathan AS, Marx AH, Weber DJ, Daniels LM (2017) Bezlotoxumab: a novel agent for the prevention of recurrent Clostridium difficile infection. Pharmacotherapy 37:1298\u20131308","journal-title":"Pharmacotherapy"},{"key":"5697_CR57","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.humimm.2019.02.008","volume":"80","author":"A Kumar","year":"2019","unstructured":"Kumar A, Harjai K, Chhibber S (2019) A multiepitopic theoretical fusion construct based on in-silico epitope screening of known vaccine candidates for protection against wide range of enterobacterial pathogens. Hum Immunol 80:493\u2013502","journal-title":"Hum Immunol"},{"key":"5697_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-007462","author":"S Lancione","year":"2022","unstructured":"Lancione S, Alvarez JV, Alsdurf H, Pai M, Zwerling AA (2022) Tracking changes in national BCG vaccination policies and practices using the BCG World Atlas. BMJ Glob Health. https:\/\/doi.org\/10.1136\/bmjgh-2021-007462","journal-title":"BMJ Glob Health"},{"key":"5697_CR59","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange C, Aaby P, Behr MA, Donald PR, Kaufmann SHE, Netea MG, Mandalakas AM (2022) 100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin. Lancet Infect Dis 22:e2\u2013e12","journal-title":"Lancet Infect Dis"},{"key":"5697_CR60","doi-asserted-by":"publisher","unstructured":"Liang Y, Wang J, Yang J, Liu J, He X (2025) Global burden and trend of tuberculosis in children and adolescents (under15 years old) from 1990 to 2021, with projections to 2040.\u00a0Front Public Health\u00a013. https:\/\/doi.org\/10.3389\/fpubh.2025.1578658","DOI":"10.3389\/fpubh.2025.1578658"},{"key":"5697_CR61","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00428-16","author":"M Lipsitch","year":"2016","unstructured":"Lipsitch M, Siber GR (2016) How can vaccines contribute to solving the antimicrobial resistance problem? mBio. https:\/\/doi.org\/10.1128\/mBio.00428-16","journal-title":"mBio"},{"key":"5697_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/vaccines7020037","volume":"7","author":"MA Liu","year":"2019","unstructured":"Liu MA (2019) A comparison of plasmid DNA and mRNA as vaccine technologies. Vaccines 7:37","journal-title":"Vaccines"},{"key":"5697_CR63","doi-asserted-by":"publisher","first-page":"e00439","DOI":"10.1128\/CVI.00439-16","volume":"24","author":"AG Loxton","year":"2017","unstructured":"Loxton AG, Knaul JK, Grode L, Gutschmidt A, Meller C, Eisele B, Johnstone H, Gvd S, Maertzdorf J, Kaufmann SHE, Hesseling AC, Walzl G, Cotton MF (2017) Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa. Clin Vaccine Immunol 24:e00439-e416","journal-title":"Clin Vaccine Immunol"},{"key":"5697_CR64","doi-asserted-by":"publisher","unstructured":"Lu B, Lim JM, Yu B, Song S, Neeli P, Sobhani N, K P, Bonam SR, Kurapati R, Zheng J, Chai D (2024) The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects. Front Immunol\u00a015. https:\/\/doi.org\/10.3389\/fimmu.2024.1332939","DOI":"10.3389\/fimmu.2024.1332939"},{"key":"5697_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127974","volume":"290","author":"L Luo","year":"2025","unstructured":"Luo L, Li Q, Xing C, Li C, Pan Y, Sun H, Yu X, Wen K, Shen J, Wang Z (2025) Antibody-based therapy: an alternative for antimicrobial treatment in the post-antibiotic era. Microbiol Res 290:127974","journal-title":"Microbiol Res"},{"key":"5697_CR66","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1093\/ofid\/ofad041","volume":"10","author":"CA MacLennan","year":"2023","unstructured":"MacLennan CA, Stanaway J, Grow S, Vannice K, Steele AD (2023) Salmonella combination vaccines: moving beyond typhoid. Open Forum Infect Dis 10:S58\u2013S66","journal-title":"Open Forum Infect Dis"},{"key":"5697_CR67","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00350-19","author":"Z Magyarics","year":"2019","unstructured":"Magyarics Z, Leslie F, Bartko J, Rouha H, Luperchio S, Sch\u00f6rgenhofer C, Schwameis M, Derhaschnig U, Lagler H, Stiebellehner L, Firbas C, Weber S, Campanaro E, Jilma B, Nagy E, Stevens C (2019) Randomized, double-blind, placebo-controlled, single-ascending-dose study of the penetration of a monoclonal antibody combination (ASN100) targeting Staphylococcus aureus cytotoxins in the lung epithelial lining fluid of healthy volunteers. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.00350-19","journal-title":"Antimicrob Agents Chemother"},{"key":"5697_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-019-1155-4","volume":"18","author":"L Marsalek","year":"2019","unstructured":"Marsalek L, Puxbaum V, Buchetics M, Mattanovich D, Gasser B (2019) Disruption of vacuolar protein sorting components of the HOPS complex leads to enhanced secretion of recombinant proteins in Pichia pastoris. Microb Cell Fact 18:119","journal-title":"Microb Cell Fact"},{"key":"5697_CR69","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5535\/arm.22036","volume":"46","author":"RS Mayer","year":"2022","unstructured":"Mayer RS, Engle J (2022) Rehabilitation of individuals with cancer. Ann Rehabil Med 46:60\u201370","journal-title":"Ann Rehabil Med"},{"key":"5697_CR70","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.1038\/s41467-022-33721-y","volume":"13","author":"RL Mayer","year":"2022","unstructured":"Mayer RL, Verbeke R, Asselman C, Aernout I, Gul A, Eggermont D, Boucher K, Thery F, Maia TM, Demol H, Gabriels R, Martens L, B\u00e9cavin C, De Smedt SC, Vandekerckhove B, Lentacker I, Impens F (2022) Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes. Nat Commun 13:6075","journal-title":"Nat Commun"},{"key":"5697_CR71","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.drudis.2019.03.002","volume":"24","author":"MJ McConnell","year":"2019","unstructured":"McConnell MJ (2019) Where are we with monoclonal antibodies for multidrug-resistant infections? Drug Discov Today 24:1132\u20131138","journal-title":"Drug Discov Today"},{"key":"5697_CR72","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ccm.2018.08.002","volume":"39","author":"ML Metersky","year":"2018","unstructured":"Metersky ML, Kalil AC (2018) Management of ventilator-associated pneumonia: guidelines. Clin Chest Med 39:797\u2013808","journal-title":"Clin Chest Med"},{"key":"5697_CR73","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","volume":"19","author":"F Micoli","year":"2021","unstructured":"Micoli F, Bagnoli F, Rappuoli R, Serruto D (2021) The role of vaccines in combatting antimicrobial resistance. Nat Rev Microbiol 19:287\u2013302","journal-title":"Nat Rev Microbiol"},{"key":"5697_CR74","doi-asserted-by":"publisher","unstructured":"Motley MP, Fries BC (2017) A new take on an old remedy: generating antibodies against multidrug-resistant gram-negative bacteria in a postantibiotic world. mSphere 2.\u00a0https:\/\/doi.org\/10.1128\/msphere.00397-00317","DOI":"10.1128\/msphere.00397-00317"},{"key":"5697_CR75","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, Johnson SC, Browne AJ, Chipeta MG, Fell F, Hackett S, Haines-Woodhouse G, Kashef Hamadani BH, Kumaran EAP, McManigal B, Achalapong S, Agarwal R, Akech S, Albertson S, Amuasi J, Andrews J, Aravkin A, Ashley E, Babin F-X, Bailey F, Baker S, Basnyat B, Bekker A, Bender R, Berkley JA, Bethou A, Bielicki J, Boonkasidecha S, Bukosia J, Carvalheiro C, Casta\u00f1eda-Orjuela C, Chansamouth V, Chaurasia S, Chiurchi\u00f9 S, Chowdhury F, Clotaire Donatien R, Cook AJ, Cooper B, Cressey TR, Criollo-Mora E, Cunningham M, Darboe S, Day NPJ, De Luca M, Dokova K, Dramowski A, Dunachie SJ, Duong Bich T, Eckmanns T, Eibach D, Emami A, Feasey N, Fisher-Pearson N, Forrest K, Garcia C, Garrett D, Gastmeier P, Giref AZ, Greer RC, Gupta V, Haller S, Haselbeck A, Hay SI, Holm M, Hopkins S, Hsia Y, Iregbu KC, Jacobs J, Jarovsky D, Javanmardi F, Jenney AWJ, Khorana M, Khusuwan S, Kissoon N, Kobeissi E, Kostyanev T, Krapp F, Krumkamp R, Kumar A, Kyu HH, Lim C, Lim K, Limmathurotsakul D, Loftus MJ, Lunn M, Ma J, Manoharan A, Marks F, May J, Mayxay M, Mturi N, Munera-Huertas T, Musicha P, Musila LA, Mussi-Pinhata MM, Naidu RN, Nakamura T, Nanavati R, Nangia S, Newton P, Ngoun C, Novotney A, Nwakanma D, Obiero CW, Ochoa TJ, Olivas-Martinez A, Olliaro P, Ooko E, Ortiz-Brizuela E, Ounchanum P, Pak GD, Paredes JL, Peleg AY, Perrone C, Phe T, Phommasone K, Plakkal N, Ponce-de-Leon A, Raad M, Ramdin T, Rattanavong S, Riddell A, Roberts T, Robotham JV, Roca A, Rosenthal VD, Rudd KE, Russell N, Sader HS, Saengchan W, Schnall J, Scott JAG, Seekaew S, Sharland M, Shivamallappa M, Sifuentes-Osornio J, Simpson AJ, Steenkeste N, Stewardson AJ, Stoeva T, Tasak N, Thaiprakong A, Thwaites G, Tigoi C, Turner C, Turner P, van Doorn HR, Velaphi S, Vongpradith A, Vongsouvath M, Vu H, Walsh T, Walson JL, Waner S, Wangrangsimakul T, Wannapinij P, Wozniak T, Young Sharma TEMW, Yu KC, Zheng P, Sartorius B, Lopez AD, Stergachis A, Moore C, Dolecek C, Naghavi M (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399:629\u2013655","journal-title":"The Lancet"},{"key":"5697_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01147","volume":"8","author":"NE Nieuwenhuizen","year":"2017","unstructured":"Nieuwenhuizen NE, Kulkarni PS, Shaligram U, Cotton MF, Rentsch CA, Eisele B, Grode L, Kaufmann SHE (2017) The recombinant Bacille Calmette-Gu\u00e9rin vaccine VPM1002: ready for clinical efficacy testing. Front Immunol 8:1147","journal-title":"Front Immunol"},{"key":"5697_CR77","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","volume":"396","author":"GA Poland","year":"2020","unstructured":"Poland GA, Ovsyannikova IG, Kennedy RB (2020) SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet 396:1595\u20131606","journal-title":"Lancet"},{"key":"5697_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1084\/jem.20182160","volume":"216","author":"R Rappuoli","year":"2019","unstructured":"Rappuoli R, Santoni A, Mantovani A (2019) Vaccines: an achievement of civilization, a human right, our health insurance for the future. J Exp Med 216:7\u20139","journal-title":"J Exp Med"},{"key":"5697_CR79","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1016\/j.vaccine.2020.03.057","volume":"38","author":"MX Rodrigues","year":"2020","unstructured":"Rodrigues MX, Yang Y, de Souza Meira EB, do Carmo Silva J, Bicalho RC (2020) Development and evaluation of a new recombinant protein vaccine (YidR) against Klebsiella pneumoniae infection. Vaccine 38:4640\u20134648","journal-title":"Vaccine"},{"key":"5697_CR80","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000003121","author":"R Rodriguez-Fernandez","year":"2021","unstructured":"Rodriguez-Fernandez R, Mejias A, Ramilo O (2021) Monoclonal antibodies for prevention of respiratory syncytial virus infection. Pediatr Infect Dis J. https:\/\/doi.org\/10.1097\/inf.0000000000003121","journal-title":"Pediatr Infect Dis J"},{"key":"5697_CR81","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00216-019-01633-4","volume":"411","author":"JP Salvador","year":"2019","unstructured":"Salvador JP, Vilaplana L, Marco MP (2019) Nanobody: outstanding features for diagnostic and therapeutic applications. Anal Bioanal Chem 411:1703\u20131713","journal-title":"Anal Bioanal Chem"},{"key":"5697_CR82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jgar.2021.08.001","volume":"27","author":"AI Samreen","year":"2021","unstructured":"Samreen AI, Malak HA, Abulreesh HH (2021) Environmental antimicrobial resistance and its drivers: a potential threat to public health. Journal of Global Antimicrobial Resistance 27:101\u2013111","journal-title":"Journal of Global Antimicrobial Resistance"},{"key":"5697_CR83","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12033-020-00241-3","volume":"62","author":"PK Satheeshkumar","year":"2020","unstructured":"Satheeshkumar PK (2020) Expression of single chain variable fragment (scFv) molecules in plants: a comprehensive update. Mol Biotechnol 62:151\u2013167","journal-title":"Mol Biotechnol"},{"key":"5697_CR84","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02349-16","author":"MJ Satlin","year":"2017","unstructured":"Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, Hamula CL, Uhlemann AC, Levi MH, Fries BC, Tang YW, Juretschko S, Rojtman AD, Hong T, Mathema B, Jacobs MR, Walsh TJ, Bonomo RA, Kreiswirth BN (2017) Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United States. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02349-16","journal-title":"Antimicrob Agents Chemother"},{"key":"5697_CR85","doi-asserted-by":"publisher","unstructured":"Senolt L (2019) Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies. F1000Res 8. https:\/\/doi.org\/10.12688\/f1000research.18688.1","DOI":"10.12688\/f1000research.18688.1"},{"key":"5697_CR86","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10096-017-3033-5","volume":"36","author":"R Sihvonen","year":"2017","unstructured":"Sihvonen R, Siira L, Toropainen M, Kuusela P, P\u00e4t\u00e4ri-Sampo A (2017) Streptococcus pneumoniae antimicrobial resistance decreased in the Helsinki Metropolitan Area after routine 10-valent pneumococcal conjugate vaccination of infants in Finland. Eur J Clin Microbiol Infect Dis 36:2109\u20132116","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5697_CR87","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.tibtech.2013.10.002","volume":"32","author":"O Spadiut","year":"2014","unstructured":"Spadiut O, Capone S, Krainer F, Glieder A, Herwig C (2014) Microbials for the production of monoclonal antibodies and antibody fragments. Trends Biotechnol 32:54\u201360","journal-title":"Trends Biotechnol"},{"key":"5697_CR88","doi-asserted-by":"publisher","first-page":"344.e341","DOI":"10.1016\/j.cmi.2014.11.016","volume":"21","author":"AJ Stewardson","year":"2015","unstructured":"Stewardson AJ, Ga\u00efa N, Fran\u00e7ois P, Malhotra-Kumar S, Del\u00e9mont C, Martinez de Tejada B, Schrenzel J, Harbarth S, Lazarevic V (2015) Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota. Clin Microbiol Infect 21:344.e341\u2013344.e311","journal-title":"Clin Microbiol Infect"},{"key":"5697_CR89","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/vaccines10040572","volume":"10","author":"N Sutharattanapong","year":"2022","unstructured":"Sutharattanapong N, Thotsiri S, Kantachuvesiri S, Wiwattanathum P (2022) Benefits of inactivated vaccine and viral vector vaccine immunization on COVID-19 infection in kidney transplant recipients. Vaccines 10:572","journal-title":"Vaccines"},{"key":"5697_CR90","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jcf.2015.08.002","volume":"15","author":"K Thomsen","year":"2016","unstructured":"Thomsen K, Christophersen L, Bjarnsholt T, Jensen P\u00d8, Moser C, H\u00f8iby N (2016) Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model. J Cyst Fibros 15:171\u2013178","journal-title":"J Cyst Fibros"},{"key":"5697_CR91","first-page":"899","volume":"102","author":"TT Timbrook","year":"2018","unstructured":"Timbrook TT, Spivak ES, Hanson KE (2018) Current and future opportunities for rapid diagnostics in antimicrobial stewardship. Med Clin 102:899\u2013911","journal-title":"Med Clin"},{"key":"5697_CR92","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41479-017-0030-5","volume":"9","author":"S Tricarico","year":"2017","unstructured":"Tricarico S, McNeil HC, Cleary DW, Head MG, Lim V, Yap IKS, Wie CC, Tan CS, Norazmi MN, Aziah I, Cheah ESG, Faust SN, Jefferies JMC, Roderick PJ, Moore M, Yuen HM, Newell ML, McGrath N, Doncaster CP, Kraaijeveld AR, Webb JS, Clarke SC (2017) Pneumococcal conjugate vaccine implementation in middle-income countries. Pneumonia (Nathan) 9:6","journal-title":"Pneumonia (Nathan)"},{"key":"5697_CR93","doi-asserted-by":"publisher","unstructured":"Tsai C-W, Morris S (2015) Approval of raxibacumab for the treatment of inhalation anthrax under the US food and drug administration \u201cAnimal Rule\u201d.\u00a0Front Microbiol\u00a06. https:\/\/doi.org\/10.3389\/fmicb.2015.01320","DOI":"10.3389\/fmicb.2015.01320"},{"key":"5697_CR94","doi-asserted-by":"publisher","first-page":"14188","DOI":"10.1038\/s41598-023-41525-3","volume":"13","author":"AA Tungekar","year":"2023","unstructured":"Tungekar AA, Ruddock LW (2023) Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli. Sci Rep 13:14188","journal-title":"Sci Rep"},{"key":"5697_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301340","volume":"10","author":"A Tvilum","year":"2023","unstructured":"Tvilum A, Johansen MI, Glud LN, Ivarsen DM, Khamas AB, Carmali S, Mhatre SS, S\u00f8gaard AB, Faddy E, de Vor L, Rooijakkers SHM, \u00d8stergaard L, J\u00f8rgensen NP, Meyer RL, Zelikin AN (2023) Antibody-drug conjugates to treat bacterial biofilms via targeting and extracellular drug release. Adv Sci (Weinh) 10:e2301340","journal-title":"Adv Sci (Weinh)"},{"key":"5697_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092126","author":"F Vacca","year":"2022","unstructured":"Vacca F, Sala C, Rappuoli R (2022) Monoclonal antibodies for bacterial pathogens: mechanisms of action and engineering approaches for enhanced effector functions. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10092126","journal-title":"Biomedicines"},{"key":"5697_CR97","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2507912","volume":"21","author":"KM Vadrevu","year":"2025","unstructured":"Vadrevu KM, Chiteti SR, Dugyala R, Aileni VK, Kunta A, Patnaik BN, Ella R (2025) Comparative immune response of Typbar TCV\u00ae (typhoid conjugate vaccine) in extremes of age: an Indian experience. Hum Vaccin Immunother 21:2507912","journal-title":"Hum Vaccin Immunother"},{"key":"5697_CR98","doi-asserted-by":"publisher","first-page":"e1470","DOI":"10.1016\/S2214-109X(24)00263-8","volume":"12","author":"A von Gottberg","year":"2024","unstructured":"von Gottberg A, Kleynhans J, de Gouveia L, Tempia S, Meiring S, Quan V, du Plessis M, von Mollendorf C, Crowther-Gibson P, Avenant T, du Plessis N, Kularatne R, Chibabhai V, Madhi SA, Klugman KP, Whitney CG, Cohen C, Ahmed K, Bamford C, Black J, Blumberg L, Brink A, Dawood H, Dlamini N, Dreyer A, du Plessis D, Ebonwu J, Erasmus L, Feldman C, Frean J, Govender N, Govind C, Haffejee S, Hamese K, Han KSS, Hoho N, Hoosien E, Howell V, Hoyland G, Hunt G, Ismail F, Ismail H, Ismail N, Ive P, Jooste P, Khantsi I, Lebaka T, Legare N, Lekalakala R, Lowman W, Mahabeer P, Maharj A, Makgoba M, Maloba M, Maluleka C, Maningi N, Marcus L, Marshall T, Mathebula R, Mathunjwa A, Mbelle N, McCarthy K, Menezes C, Miller C, Mlisana K, Moncho M, Moore D, Moremi M, Morris L, Mpembe R, Mutevedzi P, Mwansa-Kambafwile J, Naby F, Naidoo R, Nana T, Nchabeleng M, Ngomane M, Ngubane W, Njikho S, Ntuli S, Page N, Pearce V, Perovic O, Pillay K, Poswa X, Prentice E, Radebe F, Ramajathan P, Ramalwa N, Reddy K, Reubenson G, Rossouw J, Samuel C, Seetharam S, Selekisho M, Senekal M, Shuping L, Sibiya N, Sirkar S, Smit J, Smith A, Smith M, Sookan L, Sriruttan C, Thomas J, Tsitsi M, van Schalkwyk E, Variava E, Verwey C, Wadula J, Walaza S, Weyer J, Whitelaw A, Zietsman I (2024) Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005\u201319: a cohort observational study. Lancet Glob Health 12:e1470\u2013e1484","journal-title":"Lancet Glob Health"},{"key":"5697_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12010038","author":"H Wang","year":"2023","unstructured":"Wang H, Wang S, Fang R, Li X, Xing J, Li Z, Song N (2023) Enhancing TB vaccine efficacy: current progress on vaccines, adjuvants and immunization strategies. Vaccines. https:\/\/doi.org\/10.3390\/vaccines12010038","journal-title":"Vaccines"},{"key":"5697_CR100","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1930847","volume":"18","author":"KJ Whaley","year":"2022","unstructured":"Whaley KJ, Zeitlin L (2022) Emerging antibody-based products for infectious diseases: planning for metric ton manufacturing. Hum Vaccin Immunother 18:1930847","journal-title":"Hum Vaccin Immunother"},{"key":"5697_CR101","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa1602615","volume":"376","author":"MH Wilcox","year":"2017","unstructured":"Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim Y-S, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr M-B (2017) Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med 376:305\u2013317","journal-title":"N Engl J Med"},{"key":"5697_CR102","doi-asserted-by":"publisher","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","volume":"9","author":"MT Yousafzai","year":"2021","unstructured":"Yousafzai MT, Karim S, Qureshi S, Kazi M, Memon H, Junejo A, Khawaja Z, Ur Rehman N, Ansari MS, Ali R, Ujjan IU, Lohana HM, Memon NM, Hussain M, Nigar R, Bar-Zeev N, Qamar FN (2021) Effectiveness of typhoid conjugate vaccine against culture-confirmed <em>Salmonella enterica<\/em> serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study. Lancet Glob Health 9:e1154\u2013e1162","journal-title":"Lancet Glob Health"},{"key":"5697_CR103","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nbt.2025.10.005","volume":"90","author":"D Zhang","year":"2025","unstructured":"Zhang D, Liu H, Zhong Y (2025) Monoclonal antibodies production in microbial systems: current status, challenges and perspectives. New Biotechnol 90:163\u2013173","journal-title":"New Biotechnol"},{"key":"5697_CR104","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","volume":"8","author":"G Zhang","year":"2023","unstructured":"Zhang G, Tang T, Chen Y, Huang X, Liang T (2023) MRNA vaccines in disease prevention and treatment. Signal Transduct Target Ther 8:365","journal-title":"Signal Transduct Target Ther"},{"key":"5697_CR105","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1080\/19420862.2016.1229722","volume":"8","author":"C Zhou","year":"2016","unstructured":"Zhou C, Lehar S, Gutierrez J, Rosenberger CM, Ljumanovic N, Dinoso J, Koppada N, Hong K, Baruch A, Carrasco-Triguero M, Saad O, Mariathasan S, Kamath AV (2016) Pharmacokinetics and pharmacodynamics of DSTA4637A: a novel THIOMAB\u2122 antibody antibiotic conjugate against Staphylococcus aureus in mice. Mabs 8:1612\u20131619","journal-title":"Mabs"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05697-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05697-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05697-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:02:39Z","timestamp":1792882959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05697-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":105,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5697"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05697-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}